Series of Skin Whitening (Lightening) Compounds
US-2017275224-A1 · Sep 28, 2017 · US
US10227282B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10227282-B2 |
| Application number | US-201414445713-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2014 |
| Priority date | Mar 8, 2010 |
| Publication date | Mar 12, 2019 |
| Grant date | Mar 12, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of reducing the virulence of a bacterium that expresses accessory gene regulator A (AgrA) includes administering to the bacterium an amount of AgrA antagonist effective to inhibit the synthesis of one or more virulence factors by the bacterium.
Opening claim text (preview).
Having described the invention, the following is claimed: 1. A pharmaceutical composition comprising an accessory gene regulator A (AgrA) antagonist having the formula: and pharmaceutically acceptable salts thereof, and an antibiotic. 2. A pharmaceutical composition comprising an accessory gene regulator A (AgrA) antagonist having the formula: wherein R 1 and R 2 are each independently selected from the group consisting of H, hydroxy, carboxy, lower alkoxy, lower alkoxyhydroxy, lower alkyl, alkenyl, sulfonic, and halo; R 3 is a C2-C6 lower alkyl; and pharmaceutically acceptable salts thereof, and an antibiotic.
Related publications grouped by family.
Answers are generated from the same data shown on this page.